Thermo Fisher Scientific Expands China Presence Through New Customer Solutions Center
The new center will handle the delivery of novel and high-quality therapeutics by providing expertise in critical analytical processes and specialized workflows.
Thermo Fisher Scientific announced on Nov. 13, 2019 that it is opening a customer solutions center in Shanghai, China, furthering the company’s efforts to expand its presence in China. The company also recently announced the opening of a biosciences customer exploration center in Shanghai and the expansion of its clinical trials logistics facility in Suzhou, China.
According to a company press release, the new center will handle the delivery of novel and high-quality therapeutics by providing expertise in critical analytical processes and specialized workflows.
"The opening of a Pharma and BioPharma [c]ustomer [s]olution [c]enter in China demonstrates our unwavering commitment to bringing best-in-class analytical technologies to laboratories across the region and supporting quality-by-design through scientific collaboration by scientists," said Tony Acciarito, president of Thermo Fisher Scientific in China, in the press release. "The new [c]enter reinforces our mission of enabling our customers to make the world healthier, cleaner, and safer by helping laboratories in China nurture innovation and bring effective medicines to waiting patients."
"Thermo Fisher's new [c]ustomer [s]olution ]c]enter in Shanghai is a hub of collaboration that will enable scientists across China to build new analytical workflows, enhance knowledge across our thriving pharmaceutical and biopharmaceutical sector, and help build capability and expertise in the region,” added Zhong Feng, director, Shandong New Time Pharmaceutical, in the press release.
Source: Thermo Fisher Scientific
Diving Deep into Carrier-Based Formulation and Process Optimization
December 23rd 2024Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung. This paper looks at the requirements for pulmonary delivery via carrier-based inhaled powder formulations, and how jet milling can be used to manufacture effective and stable materials for these formulations
Molecular Properties of PROTACs and the Relationship to Formulation Design
December 20th 2024Analyzation of a diverse set of PROTAC (Proteolysis Targeting Chimeras – a class of TPDs) structures and their calculated properties, identifying key structure-property trends that contribute to low oral bioavailability.
